These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15574201)

  • 1. Survival of patients treated with intra-aortic balloon counterpulsation at a tertiary care center in Pakistan - patient characteristics and predictors of in-hospital mortality.
    Jafary FH; Khan SA; Kumar H; Malik NF; Kazmi KA; Dhakam S; Shafquat A; Hameed A; Tai J; Nadeem N
    BMC Cardiovasc Disord; 2004 Dec; 4():22. PubMed ID: 15574201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis?
    Drakos SG; Anastasiou-Nana MI; Terrovitis JV; Tsagalou EP; Kanakakis J; Ntalianis A; Lazaris N; Maroulidis G; Venetsanakos J; Bonios M; Nanas JN
    Coron Artery Dis; 2008 Nov; 19(7):521-6. PubMed ID: 18923249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock.
    Chen EW; Canto JG; Parsons LS; Peterson ED; Littrell KA; Every NR; Gibson CM; Hochman JS; Ohman EM; Cheeks M; Barron HV;
    Circulation; 2003 Aug; 108(8):951-7. PubMed ID: 12912817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators.
    Hussain F; Philipp RK; Ducas RA; Elliott J; Džavík V; Jassal DS; Tam JW; Roberts D; Garber PJ; Ducas J
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):540-8. PubMed ID: 21547996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
    Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
    Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U; Bauer T; Hamm C; Zahn R; Weidinger F; Seabra-Gomes R; Hochadel M; Marco J; Gitt A
    EuroIntervention; 2011 Aug; 7(4):437-41. PubMed ID: 21764661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality at 30 days in high-risk patients treated with direct or rescue stenting for acute myocardial infarction: a single center experience.
    La Vecchia L; Martini M; Sartori M; Vincenzi P; Cischele L; Righetti T; Ometto R; Fontanelli A
    J Invasive Cardiol; 2001 Oct; 13(10):689-93. PubMed ID: 11581511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with intra-aortic balloon counterpulsation over 10 years: a retrospective cohort study of 459 patients.
    Chang SN; Hwang JJ; Chen YS; Lin JW; Chiang FT
    Resuscitation; 2008 Jun; 77(3):316-24. PubMed ID: 18314247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current use of preoperative intra-aortic balloon counterpulsation in high-risk cardiac surgery: a cohort study.
    Litton E; Delaney A; Simpson JM; Raper R
    Crit Care Resusc; 2008 Sep; 10(3):188-92. PubMed ID: 18798716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraaortic balloon counterpulsation in the treatment of perioperative cardiogenic shock-complicated myocardial infarction during aortocoronary bypass surgery].
    Eremenko AA; Ziuliaeva TP; Babaev MA; Molochnokov IO; Kolpakov PE
    Anesteziol Reanimatol; 2005; (2):40-4. PubMed ID: 15938096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction.
    Cheng JM; Valk SD; den Uil CA; van der Ent M; Lagrand WK; van de Sande M; van Domburg RT; Simoons ML
    Am J Cardiol; 2009 Aug; 104(3):327-32. PubMed ID: 19616662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and clinical outcomes of patients with cardiogenic shock complicating acute myocardial infarction treated by emergent coronary angioplasty.
    Assali AR; Iakobishvili Z; Zafrir N; Solodky A; Teplitsky I; Rechavia E; Butto N; Shor N; Hasdai D; Fuchs S; Battler A; Kornowski R
    Int J Cardiovasc Intervent; 2005; 7(4):193-8. PubMed ID: 16373266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative intra-aortic balloon counterpulsation in stable patients with left main coronary disease.
    Fasseas P; Cohen M; Kopistansky C; Bowers B; McCormick DJ; Kasper K; Christenson JT; Parris TM; Miller MF
    J Invasive Cardiol; 2001 Oct; 13(10):679-83. PubMed ID: 11731684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of percutaneous coronary intervention among elderly patients in cardiogenic shock: a multicenter, decade-long experience.
    Dauerman HL; Ryan TJ; Piper WD; Kellett MA; Shubrooks SJ; Robb JF; Hearne MJ; Watkins MW; Hettleman BD; Silver MT; Niles NW; Malenka DJ
    J Invasive Cardiol; 2003 Jul; 15(7):380-4. PubMed ID: 12840234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: parameters to predict failure of IABP Support.
    Boeken U; Feindt P; Litmathe J; Kurt M; Gams E
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):324-8. PubMed ID: 19707972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-aortic counterpulsation for hemodynamic support in patients with acute ischemic versus non-ischemic heart failure.
    Lauten P; Rademacher W; Goebel B; Kretzschmar D; Figulla HR; Lauten A; Ferrari M
    J Invasive Cardiol; 2012 Nov; 24(11):583-8. PubMed ID: 23117313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial.
    French JK; Feldman HA; Assmann SF; Sanborn T; Palmeri ST; Miller D; Boland J; Buller CE; Steingart R; Sleeper LA; Hochman JS;
    Am Heart J; 2003 Nov; 146(5):804-10. PubMed ID: 14597928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does current treatment of cardiogenic shock complicating the acute coronary syndromes comply with guidelines?
    Iakobishvili Z; Behar S; Boyko V; Battler A; Hasdai D
    Am Heart J; 2005 Jan; 149(1):98-103. PubMed ID: 15660040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.